Evgeny E. Zvonkov — Head of the Division of Lymphoproliferative Diseases, Head of the Department of Hematology and Lymphoma Chemotherapy with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit, hematologist, Doctor of Medical Sciences
Evgeny Zvonkov graduated from the Far Eastern State Medical University with a degree in general medicine (1997). He completed his clinical postgraduate studies in the specialty "Hematology and blood transfusion" in the Department of Chemotherapy of Hematological Diseases and Intensive Care of the Hematological Research Center of the Russian Academy of Medical Sciences (1999 – 2002). He defended his Candidate of Medical Sciences thesis on the topic, "Primary lymphatic tumors of the stomach” and doctoral thesis on "Primary extranodal B-cell lymphatic tumors: clinic, diagnosis, treatment" (2009).
Since 2014 - Head of the Department of Hematology and Lymphoma Chemotherapy with Bone Marrow and Hematopoietic Stem Cell Transplantation Unit
The scientific and therapeutic work of Zvonkov covers the study of molecular, cytogenetic, and morphological causes of diseases of the blood system in order to identify molecular and biological markers; diagnosis improvement; adequate selection of differential therapy and disease monitoring; the study the role of oncogenic mutations in the prognosis of lymphoproliferative diseases.
Zvonkov is an active participant in numerous congresses and conferences both as a speaker and moderator of scientific events, including in 10 international conferences (poster reports – 9, oral report, China, 2019).
Zvonkov is a member of the problem Commission "Clinical Research in Hematology (Hemoblastosis; Hematopoiesis Depression; HSCT; Myelo- and lymphoproliferative diseases; Tumors of the lymphatic system; Pathology of red blood; ITP; Porphyria), transfusiology, pathology of hemostasis, surgical hematology, anesthesiology and intensive care.”
Since 2013, he has been a member of the Academic Council. He is a member of the Dissertation Council D 208.135.01. In 2016, he was awarded a certificate of merit from the Ministry of Health of the Russian Federation for services in the field of healthcare and many years of conscientious work. In 2017, he was awarded the highest medical category. Since 2018, he has been a member of the editorial board of the scientific publication "Hematology and Transfusiology", since 2022 - a member of the Expert Council of the Higher Attestation Commission.
In 2022, Zvonkov became the head of the Division of Lymphoproliferative Diseases, which is comprised of 3 departments, each of which has its own direction within the general topic of diagnosis and treatment of a wide range of lymphoproliferative diseases.
Under the guidance of Zvonkov, more than 20 clinical residents have completed clinical residency and 4 dissertations for the degree of Candidate of Medical Sciences have been completed. Currently, he is a consultant for one dissertation work for the degree of Doctor of Medical Sciences and 6 more doctoral works are planned in the future.
Under the leadership of Zvonkov, 8 local recommendations for the treatment of B- and T-cell lymphoproliferative diseases have been developed.
The total work experience is 25 years, after the award of the degree of Doctor of Medical Sciences – 11 years. In the period from 2001 to 2022, 285 publications were presented (107 were scientific articles and 178 thesis reports), including in Russian and foreign scientific publications. 192 publications are presented in journals indexed in recognized international citation systems (bibliographic databases) in the relevant fields of science. The Hirsch index according to the RSCI is 13 The Hirsch Index for Scopus is 4 The Hirsch Index for Web of Science is 5
Publications
